Cargando…

Human mast cells respond to viral infection by recruiting NK cells and T cells

Detalles Bibliográficos
Autores principales:	Burke, SM, Shmulevitz, M, Mohan, K, Lee, PWK, Issekutz, TB, Marshall, JS
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874284/ http://dx.doi.org/10.1186/1710-1492-6-S1-P15

Ejemplares similares

Does IgE-mediated mast cell activation reduce oral tolerance to food antigens?
por: Tunis, M, et al.
Publicado: (2010)

Local Toll-like receptor-mediated mast cell activation inhibits melanoma growth
por: Oldford, SA, et al.
Publicado: (2010)

Cbl-b silenced human NK cells respond stronger to cytokine stimulation
por: Lametschwandtner, Guenther, et al.
Publicado: (2015)

Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma
por: Yang, Yuanzheng, et al.
Publicado: (2015)

Analysis of Tie2 function in mast cells
por: Hirukawa, Alison, et al.
Publicado: (2010)

Desensitization induces hyporesponsiveness and cell-surface phenotype changes on mouse mast cells
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2014)

Mast cells are major contributors to the pathophysiology of Graves’ Ophthalmopathy (GO)
por: Van Steensel, L, et al.
Publicado: (2010)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

IL-17A producing mast cells as therapeutic target in spondyloarthritis
por: Yeremenko, N, et al.
Publicado: (2010)

P16-27.Optimization of the expansion of antigen-specific CD8+ T-cells for use in a viral suppression assay
por: Herman, MM, et al.
Publicado: (2009)

TLR-independent activation of NK cells during systemic inflammation
por: Rasid, O, et al.
Publicado: (2014)

Siglec-7/-9 ligands shield tumor cells from NK cell attack
por: Jandus, Camilla, et al.
Publicado: (2013)

Effects of nitric oxide-induced aldolase nitration on the glycolytic metabolites of mast cell
por: Sekar, Y, et al.
Publicado: (2010)

Microvessel density is as a prognostic factor in canine cutaneous mast cell tumors
por: Barbosa, Daniella FL, et al.
Publicado: (2013)

Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
por: Neto, Rafael T, et al.
Publicado: (2013)

Selective ablation of mast cells or basophils in mice reduces peanut-induced anaphylaxis
por: Reber, LL, et al.
Publicado: (2013)

S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication
por: Moreno Nieves, UY, et al.
Publicado: (2012)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Expression and function of FcγRII on NK cells in rhesus macaques
por: He, X, et al.
Publicado: (2012)

P24. Aviscumine enhances NK- cytotoxicity against tumor cells
por: Gamerith, G, et al.
Publicado: (2014)

Genomic scale analysis of NK cells impact on response to IFN-α
por: Ascierto, Maria L, et al.
Publicado: (2013)

Periodic fevers associated with celiac disease and marked increase of NK cells
por: Sediva, A
Publicado: (2015)

NK cells protect TCR-transgenic mice from developing fetal leukemia
por: Dubois, Sigrid, et al.
Publicado: (2014)

P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection
por: Eller, MA, et al.
Publicado: (2009)

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
por: Noordenbos, Troy, et al.
Publicado: (2011)

Mast cell degranulation contributes to neutrophil migration failure and susceptibility of diabetic mice to polymicrobial sepsis
por: Carlos, D, et al.
Publicado: (2009)

Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
por: Liacini, Abdelhamid, et al.
Publicado: (2014)

Gene expression profile of CD8 T cells from the responder and non-responder mice following immunotherapy treatment for prostate cancer
por: Dubey, Seema, et al.
Publicado: (2013)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
por: Shang, L, et al.
Publicado: (2012)

NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
por: Li, Guanqiao, et al.
Publicado: (2013)

ErbB2/HER2-specific NK cells for adoptive cancer immunotherapy
por: Zhang, Congcong, et al.
Publicado: (2013)

Radiation-induction of MMPs limited the NK-mediated anticancer immunity in lung cancer cells
por: Heo, Woong, et al.
Publicado: (2014)

Cyclic dinucleotides (CDNs) anti-tumors response by activating DC and NK cell crosstalk
por: Fu, Juan, et al.
Publicado: (2014)

ErbB2/Her2-specific NK cells for adoptive immunotherapy of glioblastoma
por: Zhang, Congcong, et al.
Publicado: (2014)

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
por: Makkouk, Amani, et al.
Publicado: (2015)

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses
por: Pellegatta, S, et al.
Publicado: (2014)

In vitro generation of allo-reactive human NK cells from umblillical cord blood CD34+ progenitor cells
por: Ahn, Yong-Oon, et al.
Publicado: (2015)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_agt0d38q0e7q59uo3krg86uums